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Background: Increased serum uric acid (SUA) is associated with dyslipidemia. However, there are conflicting data
about the role of single lipid species including non-high density lipoprotein cholesterol (non-HDL-C) in promoting
SUA accumulation. Here, we aimed to compare non-HDL-C with other traditional blood lipid profiles in relation to
hyperuricemia in a middle-aged and elderly Chinese population.
Methods: Data was collected from 9580 participants undergoing routine physical examinations in Xiangcheng
district of Suzhou. SUA, total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), and high
density lipoprotein cholesterol (HDL-C) were examined for all participants. Non-HDL-C was calculated by subtracting
HDL-C from TC. The associations of blood lipid profiles with hyperuricemia were examined in men and women,
respectively. The areas under Receiver Operating Characteristic (ROC) curves (AUCs) were compared to assess the
discriminatory value of blood lipid parameters for predicting hyperuricemia.
Results: All blood lipid parameters significantly correlated with SUA (all P values <0.001). The correlation coefficient
between SUA and TG was the highest in both genders. The correlation coefficient of non-HDL-C was higher than
HDL-C in males and was higher than TC and LDL-C but followed HDL-C in females. In male group, AUC of TG
(0.659) was greater than that of non-HDL-C (0.595) (P values <0.001). The AUC values of HDL-C, TC and LDL-C were
lower; respectively 0.581, 0.559 and 0.552. In female group, AUC was highest for TG (0.678) followed by HDL-C
(0.616), non-HDL-C (0.610), LDL-C (0.559) and TC (0.557) (all P values < 0.001).
Conclusions: In both genders, serum TG has the strongest association with hyperuricemia among blood lipid
parameters. Non-HDL-C is also significantly associated with hyperuricemia.
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Serum uric acid (SUA) is the final oxidation product of
purine metabolism in the circulation. SUA may accumu-
late in the body due to increased production or decreased
elimination [1]. High SUA is a prerequisite for gout [2] and
is also associated with the metabolic syndrome (MetS) and
its components [3] and consequently risk factors for hyper-
tension, stroke and other cardiovascular diseases (CVD)
[4-6]. Lipid profiles have been found to have a stronger as-
sociation with SUA than other MetS components [3].
Though it is well established that SUA is closely associated
with dyslipidemia, there are conflicting data about the role
of single lipid species in promoting SUA accumulation
[5,7-9]. A recent study in the Nigerians revealed that total
cholesterol (TC) and low density lipoprotein cholesterol
(LDL-C) were significantly associated with SUA [9], but
such associations were not found in the Iranians [5].
Apparently, the relationship between lipids and SUA var-
ied in different populations. In addition, a study has dem-
onstrated that non-high density lipoprotein cholesterol
(non-HDL-C) is more closely associated with CVD, com-
pared with other lipid parameters [10]. However, there are
no reports on relationship between non-HDL-C and SUA
as well as comparison of the relationships between
several lipid parameters and SUA level or hyperuricemia
in Chinese population. In present study, we analyzed the
associations of blood lipids including non-HDL-C with
hyperuricemia, and compared the associations of the lipid




All residents aged over 45 years in ten communities lo-
cated in Xiangcheng district in the suburb of Suzhou City
were examined from June, 2012 to April, 2013. Totally,
there were 9642 individuals who underwent a physical
examination. The exclusion criteria were to meet one of
the followings: (1) having clinical suspicion of chronic
renal diseases or tumors; (2) history of chronic liver dis-
ease; and (3) self-reported gout. After the exclusions,
9580 participants (4246 male and 5334 female) were in-
cluded in the final analysis. This study was approved by
Soochow University Ethics Committee. All participants
provided written informed consents.
Data collection
All the examinations were performed by trained medical
staff. Data on demographic, personal medical history were
obtained using a standardized questionnaire. Standing
height and body weight were measured with participants
wearing light clothing and without shoes. Body mass
index (BMI) was calculated as the ratio of weight in kilo-
grams to height in meters squared. Three consecutivesitting blood pressure measurements (30 seconds between
each) were taken by trained staff using a mercury sphyg-
momanometer according to a standard protocol, after
the subjects had been resting for at least 5 minutes.
The first and fifth Korotkoff sounds were recorded as
systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP), respectively. The mean of the three records
was used in analysis. All blood samples were obtained
from the antecubital vein in the morning after a requested
overnight fast (at least 8 hours). All laboratory tests were
done immediately after sampling. All the blood samples
were processed and analyzed using Roche Modular
automatic biochemical analyzer (Roche Diagnostics Ltd,
Mannheim, Germany). SUA was determined by the uricase
method (Roche Diagnostics, Mannheim, Germany). We
defined hyperuricemia as SUA > 416 μmol/L (7 mg/dL) for
men and > 357 μmol/L (6 mg/dL) for women [11]. TC and
triglyceride (TG) were measured by standard enzymatic
colorimetric methods (CHOD-PAP and GPO-PAP; Roche
Diagnostics, Mannheim, Germany). High density lipo-
protein cholesterol (HDL-C) and LDL-C were measured
by an enzymatic test (HDL-C-Plus and LDL-C-Plus; Roche
Diagnostics, Mannheim, Germany). Non-HDL-C was cal-
culated by subtracting HDL-C from TC. Fasting plasma
glucose (FPG) was examined using a standardized refer-
ence technique (GOD-PAP method; Roche Diagnostics,
Mannheim, Germany). The intra-coefficients of variation
values were less than 5.0% and the inter-assay values were
less than 9.5% for all examinations. In order to take know-
ledge of the liver and renal function of our study par-
ticipants, some important biomarkers such as aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
blood urea nitrogen (BUN), and serum creatinine (SCr)
were also tested using commercial reagents.
Statistical analysis
All statistical analyses were carried out separately by sex
because of the varied level of SUA between genders [5].
Baseline characteristics of participants were presented
and compared between participants with and without
hyperuricemia. Comparisons in the means of continuous
variables with a normal distribution were performed by
using Student’s t-test. Comparisons in medians of continu-
ous variables with a skewed distribution were performed
by using a Wilcoxon rank-sum test. As blood lipids includ-
ing TC, TG, LDL-C, HDL-C, and non-HDL-C and SUA
values were not normally distributed, correlations between
SUA and lipids were determined using Spearman’s rank
correlation test. The associations of various blood lipids
with hyperuricemia were evaluated using univariate and
multivariate non-conditional logistic regression models.
Odds ratio (OR) and 95% confidence interval (CI) for hy-
peruricemia were calculated. In the multivariate models,
variables that differ between participants with and without
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BUN, ALT, AST were included as covariates. Lastly, we
assessed the relation of the five lipid indexes with hyperuri-
cemia by computing Receiver Operating Characteristic
(ROC) curves and comparing the areas under ROC curves
(AUCs) with the Z-statistic [12]. All reported probability
values (P-values) were based on two-sided tests and P
value <0.05 was considered statistically significant. Statis-
tical analysis was conducted using SAS statistical software
(version 9.1, Cary, North Carolona, USA).
Results
Baseline characteristics
A total of 9580 participants (4246 men and 5334 women)
with an average age of 60.9 years were included in the ana-
lysis. Among them, 1270 (13.26%) participants had hyper-
uricemia. The prevalence was significantly higher in males
than that in females (16.23% vs 10.89%, P < 0.001). The
baseline characteristics of participants with and without
hyperuricemia in both genders are shown in Table 1. The
participants with hyperuricemia tended to be older and
have higher FPG, BMI, SBP, DBP, SCr, BUN, ALT and
AST compared with those without hyperuricemia in both
genders (all P < 0.05). Participants with hyperuricemia had
higher serum TC, TG, LDL-C, non-HDL-C and lower
HDL-C compared with those without hyperuricemia in
male and female groups (all P < 0.05). There were no sig-
nificant differences in heart rate between the two groups
in either males or females.Table 1 Baseline characteristics of participants by serum uric
Characteristics
Men
≤ 416 μmol/L > 416 μmol/L
N 3557 689
Age, years, mean ± SD 60.55 ± 9.78 62.10 ± 10.66
SBP, mmHg, mean ± SD 136.59 ± 18.86 140.18 ± 20.00
DBP, mmHg, mean ± SD 85.87 ± 11.61 87.98 ± 11.47
BMI, kg/m2, mean±SD 23.33±2.89 24.53±3.14
FPG, mmol/L 5.68(5.33-6.16) 5.78(5.42-6.22)
SCr, μmol/L 71(65-78) 80(72-89)
BNU, mmol/L 5.2(4.4-6.2) 5.5(4.7-6.4)
ALT, μ/L 18(14-25) 21(16-29)
AST, μ/L 22(19-26) 24(20-29)
Heart rate, bpm 75(67-83) 74(67-84)
TC, mmol/L 4.58(4.06-5.16) 4.75(4.18-5.39)
TG, mmol/L 0.94(0.70-1.36) 1.29(0.92-1.92)
HDL-C, mmol/L 1.43(1.19-1.73) 1.31(1.10-1.60)
LDL-C, mmol/L 2.49(2.08-2.94) 2.66(2.18-3.09)
Non-HDL-C, mmol/L 3.06(2.54-3.65) 3.38(2.80-3.97)
SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; F
ALT: alanine aminotransferase; AST: aspartate aminotransferase; TC: total cholesterol; T
lipoprotein cholesterol; non-HDL-C: non-high density lipoprotein cholesterol.Correlation between blood lipids and SUA
A Spearman correlation analysis was used to estimate
correlation between lipids and SUA in males and fe-
males. As shown in Table 2, in male group, SUA posi-
tively correlated to TC (r = 0.101, P < 0.001), TG (r = 0.272,
P < 0.001), LDL-C (r = 0.107, P < 0.001), and non-HDL-C
(r = 0.176, P < 0.001) and negatively correlated to HDL-C
(r = -0.166, P < 0.001). The correlations between blood
lipids and SUA were similar in female group. SUA also
correlated to TC (r = 0.114, P < 0.001), TG (r = 0.322, P <
0.001), LDL-C (r = 0.144; P < 0.001), non-HDL-C (r =
0.220; P < 0.001), and HDL-C (r = -0.233, P < 0.001). The
Spearman correlation coefficient between SUA and TG
was the highest in both males and females. The Spearman
correlation coefficient of non-HDL-C was higher than
HDL-C in males and was higher than TC and LDL-C but
followed HDL-C in females.
Association between blood lipids and hyperuricemia
As shown in Table 3, univariate logistic regression analysis
showed that ORs for hyperuricemia were significantly as-
sociated with higher TC, TG, LDL-C, non-HDL-C and
lower HDL-C (all P < 0.05) in male group. After adjust-
ment for age, FPG, BMI, SBP, DBP, SCr, BUN, ALT, and
AST, hyperuricemia was also associated with TC, TG,
HDL-C, and non-HDL-C (all P < 0.05). We did not ob-
serve a significant association between hyperuricemia and
LDL-C after multivariate adjustment. In female group,
univariate logistic regression analysis showed that ORs foracid levels in genders
Women
P-value ≤ 357 μmol/L > 357 μmol/L P-value
- 4753 581 -
<0.001 60.34 ± 9.81 66.12 ± 10.74 <0.001
<0.001 140.46 ± 19.37 148.99 ± 19.75 <0.001
<0.001 83.74 ± 11.48 86.36±11.68 <0.001
<0.001 23.53±3.14 25.26±3.67 <0.001
0.002 5.68(5.36-6.12) 5.96(5.58-6.46) <0.001
<0.001 54(49-60) 63(56-74) <0.001
<0.001 5.1(4.3-6.1) 5.7(4.8-7.0) <0.001
<0.001 16(13-22) 18(14-27) <0.001
<0.001 21(18-25) 23(19-29) <0.001
0.478 78(71-85) 77(70-86) 0.940
<0.001 4.80(4.26-5.40) 4.96(4.40-5.65) <0.001
<0.001 1.09(0.80-1.49) 1.51(1.06-2.06) <0.001
<0.001 1.51(1.27-1.77) 1.36(1.14-1.59) <0.001
<0.001 2.66(2.23-3.12) 2.82(2.35-3.33) <0.001
<0.001 3.24(2.73-3.85) 3.60(3.01-4.23) <0.001
PG: fasting plasma glucose; SCr: serum creatinine; BUN: blood urea nitrogen;
G: triglycerides; HDL-C: high density lipoprotein cholesterol; LDL-C: low density
Table 2 Spearman correlations between lipid profiles and serum uric acid by genders
Lipid indexes
Men Women
Correlation coefficient P-value Correlation coefficient P-value
Total cholesterol 0.101 <0.001 0.114 <0.001
Triglyceride 0.272 <0.001 0.322 <0.001
HDL-C -0.166 <0.001 -0.233 <0.001
LDL-C 0.107 <0.001 0.144 <0.001
Non-HDL-C 0.176 <0.001 0.220 <0.001
HDL-C: high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; non-HDL-C: non-high density lipoprotein cholesterol.
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TC, TG, LDL-C and non-HDL-C and lower HDL-C
(all P < 0.05). In multivariate models, hyperuricemia
remained significantly associated with higher TG, non-
HDL-C and lower HDL-C (all P < 0.05). We failed to ob-
serve significant associations of hyperuricemia with TC
and LDL-C.
Comparison in AUCs between non-HDL-C and traditional
lipid profiles related to hyperuricemia
Graphical comparisons of ROC curves of various blood
lipids related to hyperuricemia in males (Figure A) and
in females (Figure B) are presented in Figure 1. Figure A
shows the discriminatory values of the five lipids related
to hyperuricemia in men. AUC values for various lipids
were as follows: 0.659 for TG, 0.595 for non-HDL-C,
0.581 for HDL-C, 0.559 for TC, and 0.552 for LDL-C.
AUC was significantly greater for TG than other lipid
profiles including non-HDL-C (all P < 0.001). Non-HDL-C
was also found to have a larger AUC value than TC (P <
0.001) and LDL-C (P <0.001). There was no significant dif-












Total cholesterol 1.26(1.15-1.38) <0.0
Triglyceride 1.68(1.54-1.84) <0.0
HDL-C 0.29(0.22-0.38) <0.0
LDL-C 1.35(1.20 -1.53) <0.0
Non-HDL-C 1.53(1.39-1.68) <0.0
*Covariates for adjustment including age, systolic blood pressure, diastolic blood pr
nitrogen, alanine aminotransferase and aspartate aminotransferase. HDL-C: high densi
non-high density lipoprotein cholesterol.(P = 0.333). There was no significant difference in the AUC
value among HDL-C, TC and LDL-C. Figure B shows the
discriminatory value of the five lipids related to hyperurice-
mia in women. The AUC values were 0.678, 0.616, 0.610,
0.559, and 0.557 for TG, HDL-C, non-HDL-C, LDL-C and
TC, respectively. TG had the largest AUC value, and non-
HDL-C had higher AUC value related to hyperuricemia
than LDL-C or TC (all P < 0.001).
Discussion
In this study, we found that TG was the best lipid index as-
sociated with hyperuricemia. Following TG, non-HDL-C
was also significantly associated with hyperuricemia in
both genders. Previous studies have examined the associa-
tions of lipid profiles such as TG, TC, LDL-C and HDL-C
with hyperuricemia [13,14]. Recently, non-HDL-C was
demonstrated to be more powerful in predicting CVD
events [10] and highlighted as a key secondary target of
therapy in patients with an increased TG [15,16], which
implied that there may be a stronger association between
non-HDL-C and CVD risks compared with other lipids.
Some studies [17,18] have showed that non-HDL-C ismia associated with blood lipid levels in both genders.












essure, body mass index, fasting plasma glucose, serum creatinine, blood urea
ty lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; non-HDL-C:
Figure 1 Discriminatory powers of TG, TC, HDL-C, LDL-C and non-HDL-C for hyperuricemia by receiver operating characteristic (ROC)
curves in males (A) and females (B). AUC: areas under the curve; CI: confidence interval; TG: triglyceride; TC: total cholesterol; HDL-C: high density
lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; non-HDL-C: non-high density lipoprotein cholesterol.
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tension, diabetes, and overweight. However, no study has
compared non-HDL-C with other lipid profiles in relation
to hyperuricemia to date. Therefore, in addition to the re-
lationship between non-HDL-C and hyperuricemia, we
compared the discriminatory values of these lipid profiles
in relation to hyperuricemia. We found that TG and Non-
HDL-C had larger AUCs related to hyperuricemia com-
pared with LDL-C and TC in males and females.
Our findings are consistent with other studies [19,20] that
have reported a close link between serum TG and SUA in
some groups. Conen and colleagues conducted a study in a
population ongoing healthy examination, which demon-
strated that TG was more strongly associated with SUA
than HDL-C and TC [21]. Russo and colleagues reported
that TG had a more closely relation to SUA than other
lipids even in the healthy people [22]. The correlation co-
efficient between TG and SUA was higher than that be-
tween TC or LDL-C and SUA in the Verona Young men,
even after adjustment for other potential covariates [23].
Non-HDL-C includes all lipoproteins that contain apo-
lipoprotein B i.e. very low density lipoprotein, LDL-C,
intermediate-density lipoprotein, chylomicrons and lipo-
protein (a). Erdogan’s study showed that correlation coeffi-
cient of non-HDL-C to SUA (r = 0.382, P < 0.001) was
slightly higher than that of TG (r = 0.379, P < 0.001) and
obviously higher than those of TC, HDL-C and LDL-C in
the healthy adults [24]. It is worthwhile to note that non-
HDL-C can be accurately calculated based on all routine
lipid profiles, fasting or non-fasting, at no further expenseto the patient. Importantly, high non-HDL-C is treatable
and has already been assimilated into current treatment
guidelines.
Some previous studies found that treatment for
hypertriglyceridemia with fenofibrate or atorvastatin re-
duced SUA levels [25,26]. In addition, an animal experi-
ment study demonstrated that lowering uric acid with
allopurinol prophylactically prevented fructose-induced
hyperuricemia and hypertriglyceridemia [27]. All these
studies indicated that TG and SUA might share a com-
mon metabolic mechanism so that some drugs can re-
duce TG as well as SUA levels. Keenan et al.’s study also
suggested that increased uric acid via increased system-
atic inflammation predict insulin resistance, followed by
dyslipidemia and hepatic steatosis [28]. In addition, some
investigators tend to conclude that both hyperuricemia
and dyslipidemia reflect the common lifestyles and diet-
ary habits such as excessive alcohol consumption, high fat
diet and physical inactivity [21,29]. Reduction of TG intake
in diet has been shown to increase uric acid elimination.
However, the effect was minimal and transient [30]. Thus, a
combination of anti-hyperlipidemia and anti-hyperuricemia
agents is a good option for the treatment of hyperuricemic
patients with hypertriglyceridemia [31]. Some remedy drugs
with dual effects of lowering both TG and SUA levels are
needed to control the combined syndrome with hyperurice-
mia and hyperlipidemia.
This study has some strength that should be mentioned.
This is a large-scale survey research in a middle-aged and
elderly Chinese population and we firstly compared various
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hyperuricemia. Since men had a higher prevalence of SUA
compared with women in current study, we studied the
relations of blood lipids to hyperuricemia in men and
women separately. The important co-variables such as
hepatorenal indexes were also measured and evaluated in
our study [32,33]. To some extent, these could control po-
tential influence of some confounding factors including
hepatorenal indexes on the relations of blood lipid pro-
files to hyperuricemia. However, the results of ROC
analysis suggested that lipid indexes including TG and
non-HDL-C were not good discriminate predictors for hy-
peruricemia in this study. Therefore, some additional fac-
tors besides lipid indexes should be considered in treating
and preventing hyperuricemia, such as control of purine-
rich foods, obesity or drinking [29].
There were several limitations in this study. First, this
was a cross-sectional study and therefore a causal relation-
ship between blood lipid profiles including non-HDL-C
and risk of hyperuricemia could not be established. Sec-
ondly, data on other confounding factors such as diet, alco-
hol consumption and physical activity were not considered
in this study, although the hepatorenal indexes can reflect
accumulation of diet and alcohol consumption to some
extent.
In summary, our results show that serum TG and
non-HDL-C have stronger relations to hyperuricemia
compared with other lipid indexes. Considering the in-
creasing prevalence of hyperuricemia and its potential
links with blood lipids, it is necessary to pay more atten-
tion to TG and non-HDL-C levels in these people with
hyperuricemia.
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